由于罕见的基因型,患有严重的α-1抗素缺乏症患者的临床特征
Ilaria Ferrarotti1,2,3, Davide Piloni2, Asia Filosa4
1Centre for Diagnosis of Inherited Alpha-1 Antitrypsin Deficiency, UOC Pulmonology, San Matteo, Pavia, Italy.
Pulmonology
|December 3, 2024
概括
患有罕见基因型的α-1抗素缺乏症 (AATD) 患者的肺部健康状况与常见PI*ZZ基因型患者相似. 早期诊断罕见的基因型对于有效管理AATD至关重要.
科学领域:
- 遗传学 遗传学 是一个
- 肺部病理学 肺部病理学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 阿尔法-1抗素缺乏症 (AATD) 是一种遗传疾病,增加了肺部和肝脏疾病的风险.
- 大多数研究都集中在PI*ZZ基因型上,忽视了其他罕见的SERPINA1基因变异.
- 在SERPINA1基因中已知有500多种单核酸变异.
研究的目的:
- 为了研究由于罕见的SERPINA1基因型而导致严重AATD的患者的临床表现和呼吸道概况.
- 将这些患者与具有PI*ZZ和PI*SZ基因型的患者进行比较.
主要方法:
- 从意大利AATD注册表 (RIDA1) 录取了281名患有严重AATD的患者.
- 将患者再分为PI*ZZ (n=160),PI*SZ (n=54) 和罕见基因型PI*R (n=67) 的队列.
- 在为期三年的随访期间,分析了临床数据,包括呼吸功能,吸烟习惯和职业暴露.
主要成果:
- 在队列中没有观察到性别,吸烟,职业暴露或诊断时的年龄的统计差异.
- 患有罕见基因型 (PI*R) 的患者表现出与PI*ZZ患者相似的临床特征和呼吸道概况.
- 在罕见的基因型和PI*SZ患者组之间发现了显著的差异.
结论:
- 罕见的SERPINA1基因型患者的严重AATD与常见的PI*ZZ基因型呈现类似.
- 对PI*R受试者的临床管理策略应考虑与PI*SZ相比,他们有着独特的形象.
- 对罕见基因型的早期和准确诊断对于最佳的患者护理至关重要.
相关概念视频
01:23Cystic Fibrosis: Pathogenesis
186
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
186
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:20COPD: Pathogenesis and Clinical Features
232
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
232
01:20Inborn Errors of Metabolism
127
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
127
01:30Acute Respiratory Failure-III
158
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
158
01:21Acute Respiratory Failure-II
174
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
174